Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPRY2 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-15 |
mRNA | LYST | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
mRNA | SLC35D2 | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-13 |
mRNA | ZFP36L2 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | HSD17B11 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |
mRNA | SH3TC2 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-12 |
mRNA | GKAP1 | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-12 |
mRNA | IRF2BP2 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | SPECC1L-ADORA2A | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-11 |
mRNA | GPR35 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-11 |